Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 926 | 2018 |
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial SJ Connolly, JW Eikelboom, J Bosch, G Dagenais, L Dyal, F Lanas, ... The Lancet 391 (10117), 205-218, 2018 | 399 | 2018 |
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY … KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ... The lancet Diabetes & endocrinology 7 (8), 618-628, 2019 | 247 | 2019 |
A multifaceted intervention to improve treatment with oral anticoagulants in atrial fibrillation (IMPACT-AF): an international, cluster-randomised trial D Vinereanu, RD Lopes, MC Bahit, D Xavier, J Jiang, HR Al-Khalidi, W He, ... The Lancet 390 (10104), 1737-1746, 2017 | 193 | 2017 |
MiR-486 and miR-92a identified in circulating HDL discriminate between stable and vulnerable coronary artery disease patients LS Niculescu, N Simionescu, GM Sanda, MG Carnuta, CS Stancu, ... PloS one 10 (10), e0140958, 2015 | 167 | 2015 |
Surgical treatment of ventricular septal defect complicating acute myocardial infarction. Experience of a north Italian referral hospital G Cerin, M Di Donato, D Dimulescu, V Montericcio, L Menicanti, A Frigiola, ... Cardiovascular Surgery 11 (2), 149-154, 2003 | 96 | 2003 |
Perspectives on hypertension's prevalence, treatment and control in a high cardiovascular risk East European country: data from the SEPHAR III survey M Dorobantu, OF Tautu, D Dimulescu, C Sinescu, P Gusbeth-Tatomir, ... Journal of Hypertension 36 (3), 690-700, 2018 | 73 | 2018 |
Dysfunctional high-density lipoproteins have distinct composition, diminished anti-inflammatory potential and discriminate acute coronary syndrome from stable coronary artery … MG Carnuta, CS Stancu, L Toma, GM Sanda, LS Niculescu, M Deleanu, ... Scientific reports 7 (1), 7295, 2017 | 66 | 2017 |
Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome G Batra, TG Lakic, J Lindbäck, C Held, HD White, RAH Stewart, W Koenig, ... JAMA cardiology 6 (12), 1440-1445, 2021 | 56 | 2021 |
Hyperglycemia determines increased specific microRNAs levels in sera and HDL of acute coronary syndrome patients and stimulates microRNAs production in human macrophages N Simionescu, LS Niculescu, MG Carnuta, GM Sanda, CS Stancu, ... PLoS One 11 (8), e0161201, 2016 | 50 | 2016 |
Acute myocardial infarction mortality rates and trends in Romania between 1994 and 2017 S Ioacara, AC Popescu, J Tenenbaum, DR Dimulescu, MR Popescu, ... International Journal of Environmental Research and Public Health 17 (1), 285, 2020 | 42 | 2020 |
Prognostic role of left atrial volume in elderly patients with symptomatic stable chronic heart failure: comparison with left ventricular diastolic dysfunction and B‐type … BA Popescu, AC Popescu, F Antonini‐Canterin, D Rubin, P Cappelletti, ... Echocardiography 24 (10), 1035-1043, 2007 | 42 | 2007 |
Hypertension and acute coronary syndromes in Romania: data from the ISACS-TC registry M Dorobantu, OF Tautu, A Fruntelata, L Calmac, G Tatu-Chitoiu, V Bataila, ... European Heart Journal Supplements 16 (suppl_A), A20-A27, 2014 | 23 | 2014 |
Relation of lipoprotein (a) levels to incident type 2 diabetes and modification by alirocumab treatment GG Schwartz, M Szarek, VA Bittner, DL Bhatt, R Diaz, SG Goodman, ... Diabetes Care 44 (5), 1219-1227, 2021 | 22 | 2021 |
Impact of associated significant aortic regurgitation on left ventricular remodeling and hemodynamic impairment in severe aortic valve stenosis AC Popescu, F Antonini-Canterin, R Enache, GL Nicolosi, R Piazza, ... Cardiology 124 (3), 174-181, 2013 | 22 | 2013 |
Efficacy and safety of dapagliflozin in type 2 diabetes according to baseline blood pressure: observations from DECLARE-TIMI 58 trial RHM Furtado, I Raz, EL Goodrich, SA Murphy, DL Bhatt, LA Leiter, ... Circulation 145 (21), 1581-1591, 2022 | 20 | 2022 |
Takotsubo cardiomyopathy and transient thyrotoxicosis during combination therapy with interferon-alpha and ribavirin for chronic hepatitis C CS Martin, LN Ionescu, CG Barbu, AE Sirbu, IM Lambrescu, IS Lacau, ... BMC Endocrine Disorders 14, 1-7, 2014 | 14 | 2014 |
The impact of bariatric surgery on diabetes and other cardiovascular risk factors E Lechea, M Popescu, D Dimulescu, D Godoroja, C Copaescu Chirurgia 114 (6), 725, 2019 | 12 | 2019 |
New national epidemiological survey for the assessment of trend in hypertension’s prevalence, treatment and control among the adult population of Romania: SEPHAR III: design … M Dorobantu, R Darabont, D Dimulescu, C Sinescu, P Gusbeth Tatomir, ... J Hypertens Res 2 (4), 143-152, 2016 | 12 | 2016 |
[OP. 6C. 01] NEW EPIDEMIOLOGIC NATIONAL REPRESENTATIVE SURVEY: SEPHAR III-MAIN RESULTS M Dorobantu, R Darabont, D Dimulescu, C Sinescu, ... Journal of Hypertension 35, e60, 2017 | 4 | 2017 |